Agenus is Bicycle's top competitor. Agenus was founded in 1994 in Lexington, Massachusetts. Agenus competes in the Biotechnology field. Agenus generates $68.2M more revenue than Bicycle.
Bicycle VS Pieris
Pieris is perceived as one of Bicycle's biggest rivals. Pieris's headquarters is in Boston, Massachusetts, and was founded in 2001. Like Bicycle, Pieris also competes in the Biotechnology industry. Pieris generates 115% of Bicycle's revenue.
AstraZeneca's Imfinzi (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy ...
FDA approved AstraZeneca's Imfinzi regimen for muscle-invasive bladder cancer, while the EU backed Calquence combo for untreated mantle cell lymphoma. ...
AstraZeneca announced on Monday that it secured a US regulatory approval and a positive EU recommendation for two of its oncology therapies, Imfinzi an...
Frequently Asked Questions about Bicycle
Who are Bicycle's top competitors?
Bicycle's top 3 competitors are Agenus, Pieris, Stemline.
Who is similar to Bicycle?
Agenus is the most similar to Bicycle. Pieris and Stemline are also similar to Bicycle.